Literature DB >> 20072151

Alloreactive microenvironment after human hematopoietic cell transplantation induces genomic alterations in epithelium through an ROS-mediated mechanism: in vivo and in vitro study and implications to secondary neoplasia.

M Themeli1, L Petrikkos, M Waterhouse, H Bertz, E Lagadinou, N Zoumbos, J Finke, A Spyridonidis.   

Abstract

We hypothesized that chronic tissue stress due to interaction of alloreactive donor cells with host epithelium after allogeneic hematopoietic cell transplantation (allo-HCT) may cause genomic alterations. We therefore analyzed 176 buccal samples obtained from 71 unselected allotransplanted patients for microsatellite instability (MSI). MSI was observed in 52% of allotransplanted patients but never in 31 healthy or autotransplanted controls. The patient age, the donor age, a female-to-male transplantation and a low number of CD34(+) cells in the graft were significantly correlated with genomic instability. There was a trend for increasing risk of MSI for patients who experienced severe graft-vs-host disease. Secondary malignancy was diagnosed in five (14%) of the MSI(+) and only in one (3%) MSI(-) patient. In an in vitro model of mutation analysis we found significant induction of frameshift mutations and DNA strand breaks in HaCaT keratinocytes co-cultured with mixed lymphocyte cultures (MLCs) but not after their exposure to interferon-gamma, tumor necrosis factor-alpha, transforming growth factor-beta (TGF-beta), MLC supernatant, peripheral blood mononuclear cells (PBMCs) or phytohemagglutinin-stimulated PBMC. A reactive oxygen species-mediated mechanism is implicated. The in vivo and in vitro data of our study show that alloreactions after allo-HCT may induce genomic alterations in epithelium. Progress in understanding DNA damage and repair after allo-HCT can potentially provide molecular biomarkers and therapeutic targets.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20072151     DOI: 10.1038/leu.2009.284

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  13 in total

1.  DNA chimerism and its consequences after allogeneic hematopoietic cell transplantation.

Authors:  Maria Themeli; Miguel Waterhouse; Juergen Finke; Alexandros Spyridonidis
Journal:  Chimerism       Date:  2011-01

2.  Busulfan Pharmacokinetics and Precision Dosing: Are Patients with Fanconi Anemia Different?

Authors:  Parinda A Mehta; Chie Emoto; Tsuyoshi Fukuda; Brian Seyboth; Ashley Teusink-Cross; Stella M Davies; Jamie Wilhelm; Kirsten Fuller; Alexander A Vinks; Farid Boulad
Journal:  Biol Blood Marrow Transplant       Date:  2019-07-18       Impact factor: 5.742

Review 3.  Second Malignancies after Hematopoietic Stem Cell Transplantation.

Authors:  Ivetta Danylesko; Avichai Shimoni
Journal:  Curr Treat Options Oncol       Date:  2018-02-08

4.  Secondary oral cancer following hematopoietic cell transplantation.

Authors:  Stella Santarone; Annalisa Natale; Stefano Angelini; Gabriele Papalinetti; Doriana Vaddinelli; Andrea Di Bartolomeo; Paolo Di Bartolomeo
Journal:  Bone Marrow Transplant       Date:  2020-11-24       Impact factor: 5.483

5.  p53 phosphorylation and TP53 copy-number alterations in chronic graft-versus-host oral lichen preceding squamous cell carcinoma.

Authors:  Maxime Battistella; Wendy Cuccuini; Morad Elbouchtaoui; Christophe Leboeuf; Louis-François Plassa; Fatiha Bouhidel; Arnaud Rigolet; Véronique Meignin; Gérard Socié; Philippe Ratajczak; Anne Janin
Journal:  J Invest Dermatol       Date:  2013-09-04       Impact factor: 8.551

6.  Oxidative stress leads to increased mutation frequency in a murine model of myelodysplastic syndrome.

Authors:  Yang Jo Chung; Carine Robert; Sheryl M Gough; Feyruz V Rassool; Peter D Aplan
Journal:  Leuk Res       Date:  2013-08-16       Impact factor: 3.156

7.  Radiation-free, alternative-donor HCT for Fanconi anemia patients: results from a prospective multi-institutional study.

Authors:  Parinda A Mehta; Stella M Davies; Thomas Leemhuis; Kasiani Myers; Nancy A Kernan; Susan E Prockop; Andromachi Scaradavou; Richard J O'Reilly; David A Williams; Leslie Lehmann; Eva Guinan; David Margolis; K Scott Baker; Adam Lane; Farid Boulad
Journal:  Blood       Date:  2017-02-08       Impact factor: 22.113

8.  Oral epithelial dysplasia and squamous cell carcinoma following allogeneic hematopoietic stem cell transplantation: clinical presentation and treatment outcomes.

Authors:  H Mawardi; S Elad; M E Correa; K Stevenson; S-B Woo; S Almazrooa; R Haddad; J H Antin; R Soiffer; N Treister
Journal:  Bone Marrow Transplant       Date:  2011-04-04       Impact factor: 5.483

9.  Occurrence of quadruple squamous cell carcinoma following allogeneic hematopoietic stem cell transplantation for leukemia: A case report.

Authors:  Chunhong Hu; Xue Wang; Yue Pan; Long Shu; Fang Wu
Journal:  Oncol Lett       Date:  2021-03-02       Impact factor: 3.111

Review 10.  DNA damage and repair in epithelium after allogeneic hematopoietic stem cell transplantation.

Authors:  Maria Themeli; Alexandros Spyridonidis
Journal:  Int J Mol Sci       Date:  2012-11-27       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.